Michael S. Iskra - Mar 28, 2024 Form 4 Insider Report for QuidelOrtho Corp (QDEL)

Role
Interim CEO, EVP & CCO
Signature
/s/ Phillip S. Askim, attorney-in-fact for Michael S. Iskra
Stock symbol
QDEL
Transactions as of
Mar 28, 2024
Transactions value $
-$84,998
Form type
4
Date filed
4/1/2024, 08:00 PM
Previous filing
Feb 29, 2024
Next filing
Jun 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction QDEL Common Stock Award $0 +4.93K +43.98% $0.00 16.1K Mar 28, 2024 Direct F1, F2
transaction QDEL Common Stock Tax liability -$85K -1.77K -11% $47.94 14.4K Mar 28, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction QDEL Restricted Stock Units Options Exercise $0 -4.93K -33.33% $0.00 9.85K Mar 28, 2024 Common Stock 4.93K Direct F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects release of restricted stock units that were previously reported on a Form 4.
F2 The amount of shares beneficially owned following this transaction includes an additional 291 shares due to the Reporting Person's purchase of shares pursuant to the Issuer's Employee Stock Purchase Plan.
F3 Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units.
F4 Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.
F5 4,925 shares vested on March 28, 2024; the remaining 9,850 shares will vest in equal installments on March 28, 2025 and March 28, 2026.